Clinical Trial Update: Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide Resistance [Phase 4]

View source ↗

Summary

A Phase 4 pilot trial evaluates whether interrupting enfuvirtide (Fuzeon) is feasible in patients with enfuvirtide resistance; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Fuzeon (enfuvirtide)

Snippet

Sponsor: University of California, San Francisco | Conditions: HIV Infections | Phase 4 | Status: COMPLETED